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Abstract: 
 
Background: In human blood basophils, cross-linking the high-affinity IgEreceptor FcϵRI with 
multivalent antigen activates a signaling pathway leading to Ca2+ mobilization, actin 
polymerization, shape changes, secretion, and cytokine production. Methods and Results: The 
role of tyrosine kinases in human FcϵRI signaling was explored by using human basophils 
isolated by Percoll gradient centrifugation followed by negative and/or positive selection with 
antibody-coated magnetic beads. FcϵRI cross-linking of more than 95% pure basophil 
preparations activates the protein-tyrosine kinases Lyn and Syk, previously linked to FcϵRI-
coupled rodent mast cell activation, as well as Zap-70, previously implicated in T-cell receptor 
signaling, and causes the tyrosine phosphorylation of multiple proteins. The presence of Lyn, 
Syk, and Zap-70 in basophils was confirmed by Western blotting in lysates of highly purified 
basophils and independently by confocal fluorescence microscopy in cells labeled 
simultaneously with kinase-specific antibodies and with the basophil-specific antibody 2D7. 
Comparable amounts of Lyn and Syk were found in basophils and B cells, whereas T cells 
appear to have greater amounts of Zap-70 than basophils. The tyrosine kinase inhibitor 
piceatannol spares IgE-mediated Lyn activation but inhibits IgE-induced Syk and Zap-70 
activation as well as overall protein tyrosine phosphorylation and secretion. Overall protein-
tyrosine phosphorylation increases steadily over a range of anti-IgE concentrations that are low 
to optimal for secretion. However, tyrosine phosphorylation continues to increase at high anti-
IgE concentrations that elicit very little secretion (the characteristic high-dose inhibition of 
secretion). Conclusions: Our data demonstrate the association of anti-IgE–stimulated, protein-
tyrosine phosphorylation by a cascade of tyrosine kinases, including Zap-70 as well as Lyn and 
Syk, with the initiation of FcϵRI-mediated signaling in human basophils. 
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Abbreviations 
Anti-PY: Antiphosphotyrosine antibodies 
BSA: Bovine serum albumin 
EDTA: Ethylenediamine tetraacetic acid 
FcϵRI: High-affinity IgE receptor 
FITC: Fluorescein isothiocyanate 
HBSS: Hanks’ buffered saline solution 
ITAM: Immunoreceptor tyrosine activation motif 
mAb: Monoclonal antibody 
PBS: Phosphate-buffered saline 
PKC: Protein kinase C 
SDS-PAGE: Sodium dodecyl sulfate–polyacrylamide gel electrophoresis 
TCR: T-cell receptor 
RT-PCR: Reverse transcription–polymerase chain reaction 
 
The high-affinity IgE receptor FcϵRI is expressed on primary and cultured basophils and mast 
cells as well as on human monocytes,1 eosinophils,2 dendritic cells,3, 4 and Langerhans cells.5 
Cross-linking this receptor with multivalent antigen is the initial event leading to allergy, asthma, 
and other immediate hypersensitivity reactions. Despite its clear clinical importance, studies on 
early events linking FcϵRI cross-linking to downstream signaling pathways have been largely 
restricted to rodent mast cell lines. In particular, work in the RBL-2H3 rat mast cell model has 
shown that FcϵRI-mediated cell activation is initiated by the activation of a series of receptor-
associated tyrosine kinases, including Lyn and Syk,6, 7, 8 and is propagated by the tyrosine 
phosphorylation and activation of substrates that include the receptor’s own β and γ subunits,9, 10 
two phospholipase C γ isoforms,11, 12, 13 the 85 kd regulatory subunit of phosphatidylinositol 3-
kinase (PI 3-kinase),14, 15 Bruton’s kinase,16 and others including the GTP/GDP exchange protein 
Vav17 and the adaptor protein Grb2,18both implicated in the activation of ras and related 
GTPases. These early events in turn result in Ca2+ mobilization, GTPase activation, and the 
activation of multiple downstream enzymes including protein kinase C (PKC) isoforms and Erk 
and Jnk MAP kinase family members.19, 20, 21 A variety of cellular responses ensue. Biologic 
responses that occur within seconds to minutes of FcϵRI cross-linking include secretion, F-actin 
assembly, membrane ruffling, and the assembly of actin plaques mediating increased cell-
substrate adhesion.22 Increased cytokine gene expression is typically detected within 1 to 4 hours 
after receptor activation. 
 
In human basophils, it has been demonstrated that FcϵRI cross-linking induces Ca2+ mobilization 
from both cytoplasmic stores and from influx,23, 24 activates PKC,25, 26 and leads to secretion, 
actin polymerization,27 shape changes,28, 29 and cytokine production.30, 31 An extensive literature 
describes the kinetics of IgE-mediated secretion in these cells,32, 33, 34, 35, 36 demonstrates the 
substantial variability between donors in receptor density and receptor-mediated 
responses,37, 38, 39, 40 and shows that coligation of independently expressed cytokine receptors can 
prime basophils for enhanced responses to FcϵRI cross-linking.41, 42, 43 It has been established 
that human basophils can be activated through G-protein– coupled receptors that bind 
chemotactic peptides and chemokines as well as by FcϵRI cross-linking that presumably 
activates a tyrosine kinase–coupled signaling pathway.44, 45, 46, 47, 48, 49 However, the biochemical 
events that initiate and propagate the signaling cascade have not been well characterized in 
human basophils. 
 
The purpose of this study was to identify the FcϵRI-activated protein-tyrosine kinases of normal 
human basophils and to define the relation between FcϵRI-mediated protein phosphorylation and 
degranulation. Our results identify Zap-70, previously only associated with the T-cell receptor, to 
be among the anti-IgE–activated kinases in human basophils; they implicate the activation of 
protein-tyrosine kinases in the initiation of the FcϵRI-coupled signaling cascade; and they show 
that the protein-tyrosine phosphorylation response can be uncoupled from secretion at high 
concentrations of anti-IgE cross-linker. 
 
METHODS 
 
Antibodies 
 
The basophil-specific mouse monoclonal antibody (mAb) 2D750 was a gift from Dr L. Schwartz 
(Medical College of Virginia, Richmond). mAb 2D7 was fluorescein isothiocyanate (FITC)-
labeled with the FluoReporter FITC Protein Labeling Kit (Molecular Probes, Eugene, Ore.) at a 
1:60 molar ratio of FITC to antibody. Affinity-purified rabbit polyclonal antiphosphotyrosine 
antibodies (anti-PY) were prepared by G. Deanin and J. Potter (University of New Mexico).51 
The IgG mouse mAb 29C6 against the FcϵRI (IgE binding) subunit52 was a gift from Dr R. 
Chizzonite (Hoffman-La Roche, Nutley, NJ). Human IgE prepared from human myeloma plasma 
was obtained from Cortex Biochem, San Leandro, Calif. Goat anti-human IgE antibodies were 
isolated from serum by affinity chromatography and were obtained from Biosource, Camarillo, 
Calif. Rabbit polyclonal anti-Syk antibodies were a gift of Dr. R. Geahlen, Purdue University.53 
Rabbit polyclonal antibodies to Lyn and to Zap-70 were obtained from Santa Cruz 
Biotechnology, Santa Cruz, Calif. Horseradish peroxidase–rabbit immunoglobulin antibody were 
purchased from Amersham Corp. (Arlington Heights, Ill.). Anti–Zap-70 antibodies were not 
cross-reactive with the closely related Syk gene product, as determined by the manufacturer and 
in our own laboratory (Fig. 2, C). 
 
Cell purification 
 
Venous blood (100 to 450 mL) was collected from normal donors who had given informed 
consent as approved by the Human Studies Committee at the University of New Mexico. 
Heparin (0.01% vol/vol) was added as anticoagulant. None of the donors were atopic by history. 
For larger volumes of blood (>300 mL) the whole blood was first centrifuged at 2000 g for 5 
minutes and the buffy coat obtained. Whole blood or buffy coat was mixed 1:1 with modified 1× 
Hanks’ buffered saline solution (HBSS, Gibco-BRL, Grand Island, N.Y.), layered over 
discontinuous Percoll gradients, and centrifuged at 750 g for 15 minutes with no brake, resulting 
in a Percoll-enriched basophil population.54 Purities from this initial step ranged from 20% to 
73%. For experiments requiring a highly purified basophil population, the negative selection 
technique of Bjerke et al.55 was used with some modifications. Briefly, the Percoll-enriched 
basophils were incubated with mouse antibodies against contaminating cells; CD3 or CD4 and 
CD8 (T cells), CD14 (monocytes), CD16 (neutrophils and natural killer cells), CD19 and CD22 
(B cells), and anti-glycophorin AB (red blood cells) (all CD antibodies from Sigma Chemical, St. 
Louis, Mo.) in phosphate-buffered saline (PBS) containing 1% bovine serum albumin (BSA) for 
30 minutes. The cells were washed with 20 ml of PBS/BSA at 800 g, and the pellet was 
resuspended in a 1:10 dilution of goat anti-mouse IgG microbeads (Miltenyi Biotec, Auburn, 
Calif.) and incubated for 15 minutes. The cells were then washed as above, resuspended in 200 
μL of PBS/BSA, and applied to a MidiMacs separation column. For increased purities in some 
experiments, positive selection with antibody to the chain of the IgE receptor (29C6; 2 μg/mL) 
was used in combination with the MidiMacs beads followed by cell sorting of these cells with 
the basophils removed from other cells on the basis of their forward and side-scatter 
characteristics.54 Sorted cells contained more than 99% basophils with no other cells detected in 
these preparations as determined by Wright’s stain. All negative and positive selection 
procedures were performed at 4° C to prevent activation of the cells. 
 
To compare the amounts of Lyn, Syk, and Zap-70 in basophils versus B cells (Lyn and Syk) or T 
cells (Zap-70) and to obtain B cells to immunoprecipitate Syk, the monocyte/lymphocyte 
fraction obtained after Percoll-gradient centrifugation described above was washed twice with 
PBS/BSA followed by incubation with mouse antibodies to CD19 and CD22 (B cells) or a 
combination of CD3, CD4, and CD8 (T cells) for 30 minutes at 4° C. The cells were isolated 
with goat anti-mouse IgG microbeads and MidiMacs separation columns as described above. 
Wright-stained analysis of cytospin preparations revealed a homogenous cell population in all 
experiments. 
 
Immune complex kinase assays 
 
Highly purified (≥95%) basophils were isolated by use of the negative selection method 
described above. Suspensions of basophils (2.0 to 7.8 × 10 5 cells/condition, depending on cell 
yield) were primed for 1 hour with human IgE (10 μg/mL), washed with HBSS= (HBSS without 
Ca2+ or Mg2+),56 and equal aliquots incubated with prewarmed HBSS+ (HBSS with 1 mmol/L 
CaCl2 and 1 mmol/L MgCl2) with (activated) or without (nonactivated) 5 μg/mL of goat anti-
human IgE for 5 minutes at 37° C. Supernatants were collected for histamine release analysis as 
described below. In some experiments, piceatannol (10 μg/mL) was present during the last 30 
minutes of priming and during activation. Cell activation was stopped by the addition of ice-cold 
PBS containing 0.01 mol/L ethylenediamine tetraacetic acid (EDTA) (PBS/EDTA) and 
centrifugation. All procedures were performed in duplicate. In one set of samples, the pellets 
were lysed in 400 μL of 50 mmol/L Tris, pH 7.5, 150 mmol/L NaCl, 1% Brij, 1 mmol/L sodium 
orthovanadate, and 1 μg/mL each of antipain and leupeptin (lysis buffer) and incubated for 10 
minutes on ice. Immune complexes were generated by incubating clarified supernatants with 
anti-Syk, anti-Lyn, anti–Zap-70, or anti-PY antibodies; the antibodies were preadsorbed to 
protein A-Sepharose beads (Pharmacia, Uppsala, Sweden) as described.57 Kinase activity was 
measured by adding 40 μL of kinase buffer (25 mmol/l HEPES, 10 mmol/L MnCl2, pH 7.5) 
containing 10 μCi of [γ-32P]ATP (Amersham, 3000 Ci/mmol) to the washed immune complexes 
and transferred to a 30° C heat block for 15 minutes. Precipitates were washed three times with 1 
mL of ice-cold kinase buffer, followed by the addition of 40 μL of Laemmli sample buffer 
containing 5% 2-mercaptoethanol and proteins separated by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) on a 10% gel (5.0 to 8.0 × 10 5 cell 
equivalents/lane). Equal numbers of cell equivalents from activated and nonactivated samples 
were applied to the gel for each of the kinase experiments. Molecular weight markers (Gibco-
BRL, 10 kd ladder) were included in each gel. The gels were dried and the 32P-labeled proteins 
were visualized by autoradiography. The duplicate samples were separated by SDS-PAGE, 
followed by blotting with antikinase antibodies (see below) to ensure that activation does not 
affect the immunoprecipitation of kinases. 
 
Western blotting 
 
Highly purified basophils (96% to >99% pure) were obtained by negative selection followed by 
positive selection and cell sorting as described above. Cell pellets were resuspended at a 
concentration of 5 × 10 6 cells/mL in lysis buffer, vortexed, and held on ice for 10 minutes. 
Insoluble material was removed by centrifugation at 10,000 g for 5 minutes. The lysate was 
mixed 1:1 (vol/vol) with Laemmli sample buffer [2% SDS (wt/vol), 10% (vol/vol) glycerol, 60 
mmol/L Tris (pH 6.8), and 0.1% bromophenol blue], heated at 95° C for 5 minutes, and applied 
to a 10% polyacrylamide gel (1 × 10 5 cell equivalents/lane or 20 μg/mL). Molecular weight 
markers (Gibco-BRL) were included in each gel. After SDS-PAGE, proteins were transferred to 
nitrocellulose with a semidry apparatus at 400 mA for 1 hour. Membranes were blocked for 1 
hour with Blotto (5% nonfat milk and 0.05 mol/L Tween-20 in PBS) and washed three times 
with Tris-buffered saline containing 0.05% (vol/vol) Tween 20, pH 7.4 (TTBS). Membrane 
strips were incubated overnight at 4° C with 1 μg/mL each of anti-Syk, anti-Lyn, or anti–Zap-70 
antibodies in PBS/BSA or with normal rabbit serum as a negative control (1:500 dilution). 
Membranes were washed three times with TTBS, incubated with 125I-labeled donkey anti-rabbit 
IgG (0.5 μCi/ml; Amersham, UK) in PBS/BSA for 1 hour at RT, washed six times with TTBS, 
then dried and analyzed by autoradiography. In some experiments, Western blotting was 
performed with antikinase antibodies and peroxidase-conjugated secondary antibodies followed 
by enhanced chemiluminescence detection reagents (Amersham Corp.) to increase sensitivity. 
 
To determine whether anti–Zap-70 antibodies cross-react with Syk, anti-Syk immunoprecipitates 
were generated from CD19/CD22-purified human B-cell lysates, separated by SDS-PAGE, and 
immunoblots probed with either anti-Syk or anti–Zap-70 antibodies. Briefly, lysate from 1 × 
10 6 B cells was clarified by microcentrifugation (10,000 g for 5 minutes at 4° C) and incubated 
with protein A-Sepharose beads preadsorbed with anti-Syk antibodies (1 μg) or nonspecific 
rabbit immunoglobulin (1 μg). After 2 hours, beads were centrifuged at 10,000 g for 1 minute, 
washed, and resuspended in 50 μL of 2× sample buffer. Beads were boiled and samples 
containing 10 μg of protein per lane were used for SDS-PAGE (7.5% polyacrylamide gel) 
followed by transfer to nitrocellulose. Western blotting was performed as described above with 
the use of antibodies to Syk and Zap-70. 
 
To control for possible differences in the amounts of kinases immunoprecipitated from activated 
versus nonactivated cells, basophils (2.0 to 7.8 × 10 5 cells/condition) were primed and activated 
as above. After lysis of equal numbers of unstimulated basophils, immune complexes were 
generated with antikinase antibodies, separated on a 10% gel, and transferred to nitrocellulose. 
As a negative control, nonspecific rabbit IgG was substituted for the kinase antibodies during 
immunoprecipitation with activated lysates (data not shown). 
 
Immunofluorescence labeling and confocal microscopy 
 
For the simultaneous immunolocalization of tyrosine kinases and the 2D7 basophil marker, 
Percoll-enriched basophils (35% purity) were settled onto poly-L-lysine–treated coverslips for 1 
hour. Cells were fixed in 2% paraformaldehyde in PBS for 20 minutes followed by 
permeabilization with saponin (0.1% vol/vol final) for 30 minutes. The fixed cells were 
incubated overnight at 4° C in a humid chamber with the basophil-specific mAb antibody FITC-
2D7, together with rabbit polyclonal antibodies specific for Lyn, Syk, or Zap-70 (5 μg/mL final 
for each antibody). As a negative control, normal rabbit serum (Sigma, St. Louis, Mo) was 
substituted for the kinase antibodies. After overnight incubation, the slides were washed three 
times with PBS and incubated for 1 hour with a 1/500 dilution of rhodamine-conjugated donkey 
anti-rabbit IgG antibody (Jackson Labs, West Grove, Pa). After further washing with PBS, the 
coverslips were mounted onto glass slides with a fluorescence-enhancing medium (Vectashield, 
Vector Labs, Burlingame, Calif). Confocal imaging was performed with a Bio-Rad MRC-600 
Confocal Imaging System interfaced with an inverted optical microscope (Nikon Diaphot). A 
krypton-argon laser (15 mW) was used as a light source, with a 568 nm excitor filter and YHS 
(rhodamine) filter block. In double-labeling experiments, no rhodamine emission signal was 
detected in the fluorescein channel. 
 
Antiphosphotyrosine flow cytometry 
 
Percoll-enriched basophil populations (30% to 58% pure) were primed with 10 μg/mL human 
IgE for at least 1 hour followed by 10% vol/vol human AB serum for 30 minutes. In some 
experiments, piceatannol (10 μg/mL) was present during the last 30 minutes of priming and 
during activation. The cells were washed once with PBS/BSA and once with HBSS=. Cells (1 × 
10 5 cells/100 μL) were activated for varying times in suspension by incubation in prewarmed 
HBSS+ plus indicated concentrations of goat anti-human IgE. In some experiments, the Fc 
portion of human IgG (Fc blocker; 1 μg/mL, Jackson Labs, West Grove, Pa.) was added before 
the goat anti-human IgE activation. Reactions were terminated by the addition of 900 μL of ice-
cold PBS/EDTA and centrifugation for 5 minutes at 800 g for 5 minutes. Supernatants were 
stored at –20° C for histamine determination. Cell pellets were immediately resuspended in 
fixative (2% vol/vol paraformaldehyde in PBS, pH 7.4) for 20 minutes followed by the addition 
of saponin (0.02% vol/vol final) for 15 minutes at room temperature. Fixed cells were washed 
twice with PBS/BSA and incubated sequentially for 30 minutes at RT in PBS/BSA containing 1 
μg/mL anti-PY and with FITC-conjugated goat anti-rabbit antibody (1:50 in PBS/BSA; Cappell, 
Durham, N.C.) as previously described.58 Washed cells were resuspended in 0.4 mL of PBS and 
mean channel fluorescence determined for at least 10,000 cells with a Coulter Epics Elite flow 
cytometer. Basophils were identified on the basis of their forward and side-scatter pattern as 
described previously.54 
 
Histamine release 
 
Histamine in cell pellets and supernatants was measured by radioimmunoassay (AMAC-
Immunotech, Westbrook, Maine). For measurement of total histamine, 1 × 10 5 cells were lysed 
by three freeze-thaw cycles in PBS/EDTA (1 mL) followed by centrifugation at 10,000 g for 5 
minutes to remove debris; the supernatant was collected for analysis. Spontaneous and anti-IgE–
stimulated release was measured by incubating cells in parallel with or without anti-IgE and 
collecting the supernatants after centrifuging as above. IgE-mediated release was corrected for 
spontaneous release over the time course of incubation and expressed as percentage of total 
histamine present in cells held on ice. 
 
Statistics 
 
Statistical comparison of the piceatannol-treated cells with nontreated cells was carried out with 
the paired t test with Welch’s correction. The accepted level of significance was P < .02. 
 
RESULTS 
 
Human basophils contain anti-IgE–activated tyrosine kinases, including Zap-70 
 
By analogy with previous studies in RBL-2H3 cells, we expected that FcϵRI cross-linking would 
activate protein-tyrosine kinases in human basophils. This hypothesis was tested by measuring 
the in vitro tyrosine phosphorylating activities of antiphosphotyrosine (anti-PY) immune 
complexes prepared from highly purified (by negative selection) resting and anti-IgE–activated 
cells. The results of these initial experiments are given in Fig. 1, A. 
 
 
Fig. 1. A, FcϵRI cross-linking activates basophil tyrosine kinases. Equal numbers of highly purified normal human 
basophils (95% to 98%) were obtained by negative selection, primed with human IgE, and incubated in HBSS+ for 5 
minutes at 37° C with (lanes 2, 4, 6 and 8,) or without (lanes 1, 3, 5 and 7) anti-human IgE (5 μg/mL). Cells were 
lysed and the clarified supernatants immunoprecipitated with anti-PY (1, 2), anti-Lyn (3, 4), anti-Syk (5, 6), or anti–
Zap-70 antibodies (7, 8). Kinase activities in immunoprecipitates were measured as described in the Methods 
section. Results shown are representative of five different experiments, each done in duplicate. Molecular mass 
markers (kd) are indicated. B, Anti-IgE activation does not affect the amount of kinase immunoprecipitated from 
basophils. Equal numbers of highly purified (by negative selection), IgE-primed basophils (from the same 
experiment in A) were incubated with or without anti-IgE as above, lysed, and immunoprecipitated (IP)with anti-
Lyn (1, 2), anti-Syk (3, 4), anti–Zap-70 (5, 6), or irrelevant rabbit IgG antibodies (data not shown). Blots were 
probed with the same antibodies as described in the Methods section followed by horseradish peroxidase–
conjugated secondary antibodies and enhanced chemiluminescence. 
 
There was substantial kinase activity associated with anti-PY immunoprecipitates prepared from 
lysates of highly purified resting basophils (lane 1). This activity was increased in immune 
complexes from lysates of cells that had been activated by 5-minute incubation with anti-human 
IgE (lane 2). The kinases and kinase substrates in these anti-PY immune complexes included 
proteins comigrating in the 50 to 60 kd range of Src kinase family members, the 70 kd range of 
Syk family members, and in the range of the FcϵRI β and γ subunits (32 and approximately 12 
kd). 
 
To identify specific kinases involved in this stimulated response, further immune complex kinase 
assays were performed with immune complexes generated by antibodies to Lyn, Syk (tyrosine 
kinases previously identified in RBL-2H3 cells), and Zap-70 (a Syk family member found in T 
cells but not previously implicated in FcϵRI-coupled signaling). Kinase assays performed with 
anti-Lyn immunoprecipitates from resting cells show modest basal phosphorylation of 56 kd and 
53 kd proteins corresponding to the two Lyn isoforms found in hematopoietic cells (lane 3). The 
phosphorylation of the 56 kd Lyn isoform was substantially increased in immune complexes 
generated from lysates of anti-IgE–activated cells (lane 4). Similarly, in vitro kinase assays with 
anti-Syk immune complexes from lysates of unstimulated cells revealed a 72 kd phosphoprotein 
corresponding to Syk as well as several coprecipitating phosphoproteins (lane 5). The 
phosphorylation of Syk as well as several of the coprecipitating proteins was enhanced when the 
anti-Syk immune complexes were prepared from lysates of anti-IgE–stimulated cells (lane 6). 
Because phosphorylation assays in anti-PY immunoprecipitates revealed a protein band at 70 kd, 
we also performed anti–Zap-70 immune complex kinase assays. There was little or no kinase 
activity associated with anti–Zap-70 immune complexes from resting cells (lane 7). However, 
anti–Zap-70 immunoprecipitates from activated cells showed autophosphorylation of a 70 kd 
phosphoprotein, corresponding to Zap-70 that has previously been identified only in T cells (lane 
8). The mean stimulated histamine release from the experiments in Fig. 1, A was 12% in 5 
minutes (n = 8). 
 
To ensure that equal amounts of kinases are immunoprecipitated from nonactivated and activated 
cells, identical lysates of resting and activated purified basophils from the above experiments 
were incubated with antibodies to Lyn, Syk, Zap-70, or with an irrelevant rabbit IgG and the 
resulting immune complexes separated by SDS-PAGE, transferred to nitrocellulose, and Western 
blotted with antibodies to Lyn, Syk, or Zap-70. Proteins were detected with the use of 
peroxidase-conjugated secondary antibodies and enhanced chemiluminescence. The results are 
presented in Fig. 1, B. Very similar amounts of Lyn (lanes 1, 2), Syk (lanes 3, 4), and Zap-
70 (lanes 5, 6) were immunoprecipitated from resting (lanes 1, 3, 5) and activated cells (lanes 2, 
4, 6). The specificity of the kinase immunoprecipitation and detection was demonstrated by 
substituting an irrelevant rabbit IgG (rIgG) for the kinase antibodies (data not shown). 
 
These findings indicate the presence of at least three FcϵRI-associated tyrosine kinases, Lyn, 
Syk, and Zap-70, as well as multiple kinase substrates, in highly purified basophil cell 
suspensions. Because Zap-70, in particular, has previously been detected only in T cells, further 
studies were performed to ensure that these anti-IgE–activated kinases were not constituents of 
contaminating cells (<5% of these highly purified preparations) that responded during the 5-
minute assay to substances released or synthesized by activated basophils. 
 
Western blotting analysis of highly purified human basophils 
 
Basophil preparations of more than 96% purity were generated by positive selection, and their 
total detergent-soluble proteins were separated by SDS-PAGE under reducing conditions, 
followed by Western blotting. The blots were probed with antikinase antibodies or with normal 
rabbit serum (as a control), followed by 125I-conjugated anti-rabbit antibodies. As shown in, A, 
blotting lysates of positively selected basophils with antibodies to Lyn revealed two bands with 
apparent molecular masses of 53 and 56 kd (Fig. 2, A; lane 1), whereas antibodies to Syk 
revealed a band at 72 kd (Fig. 2, A; lane 2). 
 
 
Fig. 2. A, Identification of Lyn, Syk, and Zap-70 in basophils by Western blot analysis. Equal aliquots of an extract 
of positively selected, highly purified basophils (96% purity) were subjected to SDS-PAGE under reducing 
conditions in a 10% polyacrylamide gel. Sample was electrophoretically blotted onto nitrocellulose and incubated 
with antibodies to Lyn (lane 1), Syk (lane 2), or Zap-70 (lane 3) followed by 125I-rabbit antibodies and 
autoradiography. Substitution of antikinase antibodies with normal rabbit serum resulted in no staining (lane 
4). B, Comparison of kinase levels in basophils (Bas) versus B cells (Lyn and Syk) and T cells (Zap-70). Lysates of 
FACS-sorted, highly purified basophil (>99% purity; 20 μg/lane) were separated by 10% SDS-PAGE and analyzed 
by Western blot analysis with antibodies to Lyn (lanes 1, 2), Syk (lanes 3, 4), and Zap-70 (lanes 5, 6). Equal 
amounts of protein (20 μg/lane) from B cells (lanes 1, 3) and T cells (lane 5) were run in parallel to basophil lysates 
(lanes 2, 4, 6) for comparison. C, To examine any cross-reactivity of the Zap-70 antibodies to Syk, Syk was 
immunoprecipitated from CD19/CD22-selected B-cell lysates and immunoprecipitates separated on a 7.5% gel, 
immunoblotted, and stained with either antibodies to Syk (lane 1 and 2) or Zap-70 (lane 3 and 4) followed by 125I-
rabbit antibodies and autoradiography. Zap-70 antibodies showed no cross-reactivity with Syk. Substitution of anti-
Syk antibody with nonspecific rabbit immunoglobulin during the immunoprecipitation revealed no nonspecific 
binding (lanes 2 and 4). 
 
Blotting with the anti–Zap-70 antibody revealed a band with an apparent molecular mass of 70 
kd (Fig. 2, A; lane 3). There were no radiolabeled bands in lanes that were incubated with normal 
rabbit serum followed by 125I-conjugated anti-rabbit antibodies (Fig. 2, A; lane 4). Reverse 
transcription–polymerase chain reaction (RT-PCR) experiments (n = 2) also revealed the 
presence of Zap-70 mRNA in highly purified basophils (>99%) (data not shown). These 
experiments strongly support the evidence obtained with negatively selected basophils (Fig. 1) 
that human basophils contain Zap-70 as well as Lyn and Syk. 
 
We examined the relative amounts of Lyn, Syk, and Zap-70 in basophils versus B cells (Lyn and 
Syk) and T cells (Zap-70) by using Western blot analysis. To rule out the possibility of kinase-
containing contaminating cells, we used negative selection followed by positive selection with 
anti–FcϵRI-20 to obtain more than 95% basophils, which were then subjected to cell sorting; this 
resulted in a more than 99% pure basophil population. Lysates (20 μg/lane) from B or T cells as 
well as basophils were separated on 10% gels and Western blotted with kinase-specific 
antibodies. Basophils and B cells contain similar amounts of Lyn and Syk (Fig. 2, B; lanes 1 vs 2 
[Lyn] and 3 vs 4 [Syk]). T cells appear to have greater amounts of Zap-70 than do basophils 
(lanes 5 vs 6). This was confirmed by PhosphorImager analysis, which indicated approximately 
twofold more Zap-70 in T cells than in basophils (data not shown). 
 
Because Syk is 60% identical to Zap-70 in human beings,59 we considered the possibility that 
antibodies to Zap-70 could cross-react with Syk. Anti-Syk immune or nonspecific rabbit 
immunoglobulin complexes generated from lysates of human B cells were resolved by SDS-
PAGE, transferred to nitrocellulose, and the blots probed with anti-Syk and anti-Zap-70 
antibodies. As expected, anti-Syk antibody revealed a band at 72 kd (Fig. 2, C; lane 1). 
Consistent with the manufacturer’s report, anti–Zap-70 antibody showed no cross-reactivity with 
Syk (Fig. 2, C; lane 3). No Syk or Zap-70 protein was immunoprecipitated when nonspecific 
rabbit immunoglobulin was substituted for the anti-Syk antibody (Fig. 2, C; lanes 2, 4). 
 
Immunofluorescence localization of Lyn, Syk, and Zap-70 in human basophils 
 
Confocal microscopy was used to further establish the presence of Zap-70 in human basophils as 
well as to confirm the presence of Lyn and Syk in these cells. Percoll-enriched, normal human 
basophils were allowed to settle onto poly-L-lysine–coated slides and incubated with FITC-
conjugated 2D7 mAb, which specifically recognizes a granule constituent found in human 
basophils and not in other cells in peripheral blood.50 Kinases were identified in the same cells 
by simultaneous labeling with rabbit anti-kinase primary antibodies followed by rhodamine anti-
rabbit IgG. Results are shown in Fig. 3. mAb 2D7–positive cells (basophils) show fluorescence 
labeling in association with granules (Fig. 3, A, C, E,and G). 
 
Anti-2D7–positive cells were also reactive with antibodies to Lyn (B), Syk (D), and Zap-70 (F) 
but showed no labeling with normal rabbit serum (H). Staining with all three kinase antibodies 
was concentrated at the cell periphery in a somewhat irregular distribution that did not overlap 
the distribution of granules revealed by the 2D7 labeling. Previous studies in other cell types 
have similarly localized these kinases to or near the plasma membrane, although usually in a 
more uniform distribution than we observe in basophils.60, 61 In partially purified cell 
preparations, many more cells were stained with the Lyn, Syk, and/or Zap-70 antibodies than 
with mAb 2D7, consistent with the presence of these kinases in contaminating cells as well as in 
basophils. These studies independently confirm the presence in human basophils of at least three 
protein-tyrosine kinases, Lyn, Syk, and Zap-70. 
 
 
Fig. 3. Identification and localization of Lyn, Syk, and Zap-70 in human basophils by confocal immunofluorescence 
microscopy. Percoll-enriched human basophils were settled onto poly-L-lysine coverslips and labeled with a mixture 
of FITC–mouse monoclonal IgG to a basophil-specific antigen (FITC-2D7; A, C, E, G) and rabbit anti-Lyn (B), 
anti-Syk (D), or anti–Zap-70 (F) IgG, followed by rhodamine-conjugated donkey anti-rabbit IgG. Basophils 
identified by fluorescent granule staining also stained with Lyn, Syk, and Zap-70 antibodies as detected by 
rhodamine staining of the same cells. Basophils incubated with normal rabbit serum showed no staining with 
rhodamine-conjugated anti-rabbit antibodies (H). Bars, 10 μm. 
 
Piceatannol inhibits IgE-mediated human basophil degranulation 
 
In RBL-2H3 cells, low concentrations of the tyrosine kinase inhibitor piceatannol have little or 
no effect on Lyn activation and receptor subunit phosphorylation but abolish Syk activation and 
tyrosine phosphorylation of essentially all other proteins and all downstream responses.57 The 
effect of piceatannol on anti-IgE–induced histamine release in human basophils is shown in Fig. 
4, A. 
 
 
Fig. 4. A, Piceatannol inhibits IgE-mediated histamine release. Percoll-enriched basophils (40% to 50% purity) from 
three different donors were IgE-primed and incubated for different times with two concentrations of anti-human IgE 
without (open boxes) or with a 30-minute preincubation with 10 μg/mL piceatannol (dot-filled boxes). Percent 
histamine release was measured as described in the Methods section. Results are represented as standard error of the 
mean of three separate experiments (± SEM; n= 3). Spontaneous histamine release (≤6%) was unaffected by 
piceatannol and is subtracted from the values shown. Asterisks designate results for each anti-IgE concentration that 
was significantly reduced compared with cells not preincubated with piceatannol (P < .02). B, Piceatannol inhibits 
Syk and Zap-70 kinase activities. Negatively selected, highly purified basophils (≥95% pure) were IgE-primed and 
either not activated (lane 1) or activated with 5 μg/mL of antihuman IgE for 5 minutes with (lanes 2) or without 
(lane 3) a 30-minute preincubation with 10 μg/ml of piceatannol. Reactions were terminated by addition of ice-cold 
PBS/EDTA and centrifugation. Cells were lysed and their supernatants immunoprecipitated with anti-Syk, anti–Zap-
70, or anti-Lyn antibodies. Kinase activities in the immunoprecipitates were measured as described in the Methods 
section. Results shown are representative of three different experiments. Molecular mass markers (kd) are 
indicated. C, Piceatannol reduces overall cellular tyrosine phosphorylation. Duplicate samples of Percoll-enriched 
basophils (50% to 70% pure) were IgE-primed and incubated with (solid black line) or without (dotted line) anti-
human IgE alone or after a 30-minute preincubation with 10 μg/mL piceatannol (dashed line). Cells were fixed and 
labeled with rabbit anti-PY antibody followed by FITC anti-rabbit IgG. Mean fluorescence intensity per cell was 
measured for 10,000 cells/sample by flow cytometry as described in the Methods section. Results shown are in 
comparison of cells stained with the secondary antibody only (solid gray line). 
 
In basophil-enriched preparations (40% to 50% purity), piceatannol pretreatment inhibited anti-
IgE–induced histamine release greater than 10-fold (± SEM; n = 3; p< 0.02). This effect could be 
seen at both 1 and 5 μg/ml of anti-human IgE and at each time point measured. 
 
The effects of piceatannol on FcϵRI-induced Lyn, Syk, and Zap-70 activation were examined 
with the use of immune complex kinase assays. Highly purified basophils (≥95%) were activated 
with anti-human IgE with or without preincubation with piceatannol. Cells were lysed and anti-
Syk, anti-Lyn, and anti–Zap-70 immune complexes were tested for autophosphorylation, an 
index of kinase activity. The results of anti-Syk in vitro kinase assays in Fig. 4, B confirm the 
activation of Syk by FcϵRI cross-linking and show that piceatannol reduces Syk 
autophosphorylation in anti-IgE–stimulated cells to below basal levels. Preincubation with 
piceatannol also reduces Zap-70 autophosphorylation in FcϵRI–cross-linked cells to basal levels 
or lower, as shown in Fig. 4, B. In contrast, piceatannol has little or no effect on anti-IgE–
induced Lyn autophosphorylation (Fig. 4, B). These data link activation of a kinase cascade to 
FcϵRI-mediated basophil activation. 
 
The effect of piceatannol on total levels of antigen-activated tyrosine phosphorylation was 
measured by flow cytometry of antiphosphotyrosine-labeled cells.62 Total cellular tyrosine 
phosphorylation is reduced but does not fall to basal levels in basophils preincubated with 
piceatannol before anti-IgE activation (Fig. 4, C). These results are consistent with evidence 
above (Fig. 4, B) that piceatannol is a selective kinase inhibitor, blocking the activation of Syk 
and Zap-70 but permitting the continued phosphorylation and activation of Lyn. 
 
 
Fig. 5. Relation between overall level of tyrosine phosphorylation and secretion. A, Percoll-enriched basophils (30% 
to 58% pure) were primed with human IgE and incubated in suspension for 10 minutes with varying concentrations 
of anti-human IgE. IgE-primed cells were incubated with either 1 μg/mL (B) or 5 μg/mL (C) of anti-human IgE for 
varying times. Cells were fixed and labeled with rabbit anti-PY antibody followed by FITC anti-rabbit IgG. Mean 
fluorescence intensity per cell was measured for 10,000 cells/sample by flow cytometry as described in the Methods 
section. Data are expressed as a percentage above the mean fluorescence intensity in parallel unstimulated samples 
(mean ± SD; n = 3). 
 
Concentration dependence of IgE-mediated protein-tyrosine phosphorylation and 
histamine release 
 
The relation of anti-IgE–induced kinase activation to signaling responses was further explored 
with a flow cytometric assay that quantitates fluorescence in antiphosphotyrosine-labeled cells. 
Histamine release was measured in supernatants of the same cells. The results in Fig. 
5, A compare the cross-linker concentration dependence of the two responses. 
 
When incubation time is 10 minutes, the addition of increasing amounts of anti-human IgE 
(0.001 to 1 μg/mL) stimulates histamine release. However, histamine release declines rapidly in 
response to concentrations of cross-linker that are higher than 1 μg/mL anti-IgE. This is the well-
established high-dose inhibition of secretion.63, 64 It occurs whether or not the cells are 
preincubated with a human Fc-blocking peptide (data not shown), indicating that the high-dose 
inhibition of secretion is not caused by the goat anti-IgE molecules binding FcγR on basophils 
and delivering a negative signal. In contrast, tyrosine phosphorylation continues to increase to 5 
μg/mL anti-IgE and remains elevated as anti-IgE concentrations increase to 50 μg/mL (Fig. 5, A). 
 
Time course studies with 1 μg/mL and 5 μg/mL of anti-IgE are illustrated in Fig. 5, B and C. At 
both concentrations, elevated levels of total cellular tyrosine phosphorylation were detectable 
within 30 seconds of activation, reached a maximum after 5 to 10 minutes, and then declined. In 
contrast, histamine release was not significant until 3 minutes after stimulus, and secretion 
continued for at least 20 minutes (Fig. 5, B and C). The lower cross-linker concentration (1 
μg/mL) consistently resulted in higher histamine release values, whereas the higher cross-linker 
concentration (5 μg/mL) consistently gave higher overall tyrosine phosphorylation responses. 
Thus anti-IgE–induced tyrosine phosphorylation response is required for secretion, but the level 
of overall tyrosine phosphorylation does not predict the extent of secretion except in a narrow 
range of low cross-linker concentrations. 
 
DISCUSSION 
 
We have established that human basophils contain two FcϵRI-associated, protein-tyrosine 
kinases, Lyn and Syk, previously reported to be essential signal transducing components in 
rodent FcϵRI-signaling models. By Western blotting and image analysis, our data demonstrate 
the presence of two Lyn kinase isoforms, of 56 and 53 kd, in human basophils in amounts 
comparable to those found in B cells. This is consistent with previous work demonstrating 
alternatively spliced forms of Lyn encoding distinct proteins.65, 66 The presence of Lyn has been 
demonstrated in other human cell types including macrophages, platelets, and B 
lymphocytes.67, 68 
 
Our data also demonstrate that basophils and B cells have similar amounts of Syk. The presence 
of Syk in human basophils was expected on the basis of its FcϵRI association and antigen-
induced activation in RBL-2H3 cells.7, 8 In addition, Syk has been shown previously to be 
activated in receptor-coupled signal transduction pathways in B cells,69 monocytes (HL-60 
cells),70 and platelets.71 By analogy with published studies in RBL-2H3 cells, we suppose that 
Syk activation depends on the prior activation of Lyn, resulting in the phosphorylation of 
immunoreceptor tyrosine activation motifs (ITAM) in the FcϵRI β and γ subunits and the 
creation of γ-ITAM docking sites for the tandem SH2 domains of Syk. 
 
Unexpectedly, we demonstrated the presence of a third FcϵRI-associated tyrosine kinase, Zap-
70, in human basophils. Western blotting data and image analysis suggest that the levels of Zap-
70 in basophils are somewhat less than that in T cells. Zap-70 was first described in a human 
leukemia T-cell line in which it was shown to associate with the phosphorylated ζ chain of the T-
cell receptor within 15 seconds after receptor stimulation.72 Although both Zap-70 and Syk are 
members of the same kinase family and function similarly in their interactions with ITAM-
containing receptors, Zap-70 is distinct from Syk as determined by its DNA sequence and tissue 
distribution.73, 74 Zap-70 message but not protein was detected by PCR with the use of RNA from 
RBL-2H3 cells.74 The presence of Zap-70 in purified populations of human granulocytes has not 
been examined thoroughly. 
 
The tyrosine kinase inhibitor piceatannol has little or no effect on Lyn activation in human 
basophils but blocks the activity of both Syk and Zap-70 as measured in in vitro kinase assays. 
Piceatannol simultaneously abolishes secretion from human basophils. These results imply that 
the activation of Syk family members by phosphorylation may be required to initiate IgE-
mediated secretion from human basophils. 
 
Our studies to date do not distinguish the relative contributions of Syk and Zap-70 to the FcϵRI 
signaling pathway of human basophils. Further work is needed to determine if Zap-70 activates 
downstream responses that may be the same as or different from the responses to Syk activation. 
The mechanism of Zap-70 activation in anti-IgE–treated basophils is also unclear. In T cells, 
Zap-70 interacts with the T-cell receptor (TCR) ζ chain, which we have not been able to detect in 
human basophils (data not shown). However, there may be an interaction between Zap-70 and 
the FcϵRI γ chain, which is related to the αβ TCR ζ chain and replaces the ζ subunit in δγ T cells. 
Evidence to support this comes from studies in which GST fusion proteins of the Zap-70 SH2 
domains had a similar avidity for the FcϵRI γ chain ITAM peptides as it did for the TCR ζ chain 
ITAM peptides.75 Also, in COS-1 cells transfected with the FcϵRI/FcγRIIIA γ subunit, 
cotransfection with Zap-70 resulted in an increase in phagocytic signaling mediated by a Zap-
70/γ chain interaction.76 Physiologic studies in Xenopus oocytes also suggest that the γ chain and 
ζ chain may have interreceptor complementation.77 Recent work also suggests that Fc-γ and Fc-ζ 
are interchangeable in their ability to mediate T-cell development and function.78 Thus it is 
possible that Zap-70 is activated by interaction with phospho-ITAMs in the FcϵRI γ subunit. It is 
also possible that Zap-70 interacts with the ITAM of the FcϵRI β subunit. We have identified 
proteins at the 70 to 75 kd range that coimmunoprecipitate with antibodies to the FcϵRI-β chain 
in lysates from highly purified, activated basophils, although we have not been able to identify 
these proteins by using Western blotting (data not shown). 
 
Previous work with human leukemic basophils or basophils derived from bone marrow leukemic 
basophils suggested that the activation of Syk and the phosphorylation of other substrates occur 
within 1 minute after FcϵRI stimulation.79 These studies also found a positive correlation 
between histamine release and tyrosine phosphorylation. However, these studies did not identify 
either Lyn or Zap-70 activation and did not examine the effects of high concentrations of anti-
IgE on histamine release versus total cell phosphorylation in normal peripheral blood basophils. 
 
We found that high concentrations of anti-IgE cross-linker inhibit degranulation as detected by 
histamine release. Very similar kinetics of histamine release have been reported previously in 
human basophils80, 81, 82 and in other FcϵRI signaling systems.83, 84, 85 A previous explanation for 
these results is that larger FcϵRI receptor aggregates formed by multivalent antigen are rapidly 
desensitized, perhaps by conversion to a detergent-insoluble form, resulting in impaired kinase 
activation and signal transduction.32, 84, 86 However, we report that overall protein-tyrosine 
phosphorylation, a measure of the phosphorylation of kinases and their substrates, remained 
elevated at anti-IgE concentrations that no longer supported degranulation. These results are 
inconsistent with the earlier hypotheses linking the interruption of signaling with the inhibition 
of tyrosine phosphorylation. They are consistent with recent data from Wofsy et al.86 showing 
that relatively small aggregates of FcϵRI, formed by chemically cross-linked oligomers of IgE, 
maintained signaling activity for extended incubation periods as determined by protein 
phosphorylation, although the aggregates formed late in the response were less effective than the 
aggregates formed early. In a related study, Paolini et al.87 found that adding monovalent hapten 
after pronged stimulation with multivalent antigen fails to reverse the phosphorylation of 
receptor subunits and their coprecipitating proteins, even though it halts secretion. 
 
One hypothesis to explain the apparent dissociation of antigen-induced protein-tyrosine 
phosphorylation from secretion is that high-dose inhibition of secretion results, at least in part, 
from events downstream of tyrosine kinase activation. These events could be at the level of 
signal initiation: Possibly inhibitory sites on kinase substrates are phosphorylated as the intensity 
of kinase activity increases, resulting in altered enzyme activities. The presence of both 
stimulatory and inhibitory tyrosine phosphorylation sites is well established for a range of 
proteins, including Src family members.88 They could also be at the level of signal propagation. 
For example, the preferential activation of the SH2-containing inositol phospholipid 5-
phosphatase (SHIP) at higher antigen concentrations could prevent the propagation of PI 3-
kinase and phospholipase C γ–mediated signals through the accelerated removal of 
phosphatidylinositol (3,4,5)P3 (PIP3) and of Ins(1,4,5)P3. SHIP was identified as a potential 
downstream effector of FcϵRI signaling on the basis of its ability to bind FcϵRI β and γ subunit 
ITAMs in a yeast tribrid screening assay; it was subsequently shown to associate with several 
tyrosine-phosphorylated proteins in RBL-2H3 cells.89 
 
We conclude that FcϵRI-coupled signal transduction in human basophils is initiated by tyrosine 
kinase activation and modulated by events downstream of receptor-associated kinases. Further 
studies with highly purified basophils are expected to identify specific effector molecules 
involved in signal initiation, propagation, and inactivation. 
 
Acknowledgements 
 
We thank Terry Foutz for technical assistance. The equipment and technical support of the 
Cytometry and Microscopy shared facility of the UNM Cancer Research and Treatment Center 
(flow cytometry and fluorescence microscopy) and of the General Clinical Research Center of 
the UNM School of Medicine is gratefully acknowledged. We thank Drs M. Lipscomb, L. Sklar, 
M. Schuyler, and other members of the University of New Mexico Asthma SCOR program for 
their constructive criticism and consistent support and Dr Lawrence B. Schwartz for critical 
appraisal and helpful discussion of the manuscript. 
 
References 
 
1. Maurer D, Fiebiger E, Reininger B, WolffoWiniski B, Jouvin M-H, Kilgus O, et al. 
Expression of functional high affinity immunoglobulin E receptors (FceRI) on monocytes of 
atopic individuals. J Exp Med 1994;179:745-50. 
 
2. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, et al. High-affinity 
IgE receptor on eosinophils is involved in defense against parasites. Nature 1994;367:183-6. 
 
3. Wang B, Rieger A, Kilgus O, Ochiai K, Maurer D, Fodinger D, et al. Epidermal Langerhans 
cells from normal human skin bind monomeric IgE via FceRI. J Exp Med 1992;175:1353-65. 
 
4. Maurer D, Fiebiger E, Ebner C, Reininger B, Fischer GF, Wichlas S, et al. Peripheral blood 
dendritic cells express FceRI as a complex composed of FceRIa- and FceRI-gamma-chains and 
can use this receptor for IgE-mediated allergen presentation. J Immunol 1996;157:607-16. 
 
5. Bieber T, Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J, et al. Human epidermal 
Langerhans cells express the high affinity receptor for immunoglobulin E (FceRI). J Exp Med 
1992;175:1285-90. 
 
6. Eiseman E, Bolen JB. Engagement of the high-affinity IgE receptor activates src protein-
related tyrosine kinases. Nature 1992;355:78-80. 
 
7. Hutchcroft JE, Geahlen RL, Deanin GG, Oliver JM. FceRI-mediated tyrosine phosphorylation 
and activation of the 72-kDa protein-tyrosine kinase, PTK72, in RBL-2H3 rat tumor mast cells. 
Proc Natl Acad Sci U S A 1992;89:9107-11. 
 
8. Benhamou M, Ryba NJ, Kihara H, Nishikata H, Siraganian RP. Protein-tyrosine kinase 
p72syk in high affinity IgE receptor signaling: identification as a component of pp72 and 
association with the receptor gamma chain after receptor aggregation. J Biol Chem 
1993;268:23318-24. 
 
9. Bochner BS, Undem BJ, Lichtenstein LM. Immunological aspects of allergic asthma. Annu 
Rev Immunol 1994;12:295-335. 
 
10. Metzger H. The receptor with high affinity for IgE. Immunol Rev 1992;125:37-48. 
 
11. Li W, Deanin GG, Margolis B, Schlessinger J, Oliver JM. FceRI-mediated tyrosine 
phosphorylation of multiple proteins, including phospholipase Cg1 and the receptor ßg2 
complex, in RBL-2H3 rat basophilic leukemia cells. Mol Biol Cell 1992;12:3176-82. 
 
12. Barker SA, Caldwell KK, Pfeiffer JR, Wilson BS. Wortmannin-sensitive phosphorylation, 
translocation and activation of PLCg1, but not PLCg2, in antigen-stimulated RBL-2H3 mast 
cells. Mol Cell Biol 1998;6:1145-58. 
 
13. Park DJ, Min HK, Rhee SG. IgE-induced tyrosine phosphorylation of phospholipase C-g 1 in 
rat basophilic leukemia cells. J Biol Chem 1991;266:24237-40. 
 
14. Barker S, Caldwell K, Hall A, Martinez AM, Pfeiffer JR, Oliver JM, et al. Wortmannin 
blocks lipid and protein kinase activities associated with PI-3-kinase and inhibits a specific 
subset of responses induced by FceRI crosslinking. Mol Biol Cell 1995;6:1145-58. 
 
15. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, et al. Inhibition of histamine 
secretion by Wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 
cells. J Biol Chem 1993;268:25846-56. 
 
16. Price DJ, Kawakami Y, Kawakami T, Rivnay B. Purification of a major tyrosine kinase from 
RBL-2H3 cells phosphorylating FceRI g-cytoplasmic domain and identification as the Btk 
tyrosine kinase. Biochim Biophys Acta 1995;1265:133-42. 
 
17. Margolis B, Hu P, Katzav S, Li W, Oliver JM, Ullrich A, et al. Tyrosine phosphorylation of 
vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature 
1992;356:71-4. 
 
18. Turner H, Reif K, Rivera J, Cantrell DA. Regulation of the adapter molecule Grb2 by the 
FceRI in the mast cell line RBL2H3. J Biol Chem 1995;270:9500-6. 
 
19. Tsai M, Chen R-H, Tam S-Y, Blenis J, Galli SJ. Activation of MAP kinases, pp90rsk and 
pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or 
FceRI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. 
Eur J Immunol 1993;23:3286-91. 
 
20. Offermanns S, Jones SVP, Bombien E, Schultz G. Stimulation of mitogen-activated protein 
kinase activity by different secretory stimuli in rat basophilic leukemia cells. J Immunol 
1994;152:250-61. 
 
21. Santini F, Beaven MA. Tyrosine phosphorylation of a mitogen-activated protein kinase-like 
protein occurs at a late step in exocytosis: studies with tyrosine phosphatase inhibitors and 
various secretagogues in rat RBL-2H3 cells. J Biol Chem 1993;268:22716-22. 
 
22. Oliver JM, Pfeiffer JR, Wilson BS. Regulation and roles of the membrane, cytoskeletal and 
adhesive responses of RBL-2H3 rat tumor mast cells to FceRI crosslinking. In: Hamawy MM, 
editor. IgE receptor (FceRI) in mast cells and basophils. Austin, Tex.: R.G. Landes; 1997. p. 
139-66. 
 
23. Warner JA, MacGlashan DW Jr. Signal transduction events in human basophils: a 
comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and 
formyl-methionyl-leucylphenylalanine. J Immunol 1990;145:1897-905. 
 
24. MacGlashan D Jr, Guo C-B. Oscillations in free cytosolic calcium during IgE-mediated 
stimulation distinguish human basophils from human mast cells. J Immunol 1991;147:2259-69. 
 
25. Warner JA, MacGlashan DW Jr. Protein kinase C (PKC) changes in human basophils: IgE-
mediated activation is accompanied by an increase in total PKC activity. J Immunol 
1989;142:1669-77. 
 
26. Knol EF, Koenderman L, Mul E, Verhoeven AJ, Roos D. Differential mechanisms in the 
stimulus-secretion coupling in human basophils: evidence for a protein-kinase-C-dependent and 
a protein-kinase-C-independent route. Agents Actions 1990;30:49-52. 
 
27. MacGlashan DW Jr, Bochner BS, Warner JA. Graded changes in the response of individual 
human basophils to stimulation: distributional behavior of early activation events. J Leukoc Biol 
1994;55:13-23. 
 
28. Galli SJ, Dvorak AM, Dvorak HF. Basophils and mast cells: morphologic insights into their 
biology, secretory patterns, and function. Prog Allergy 1984;34:1-141. 
 
29. Dvorak AM, Newball HH, Dvorak HF, Lichtenstein LM. Antigen-induced IgE-mediated 
degranulation of human basophils. Lab Invest 1980;43:126-39. 
 
30. Schroeder JT, MacGlashan DW Jr, Kagey-Sobotka A, White JM, Lichtenstein LM. Cytokine 
generation by human basophils. J Allergy Clin Immunol 1994;94:1189-95. 
 
31. MacGlashan DW Jr. Signal transduction and cytokine production by human basophils. Chem 
Immunol 1995;61:88-113. 
 
32. Sobotka AK, Dembo M, Goldstein B, Lichtenstein LM. Antigen-specific desensitization of 
human basophils. J Immunol 1979;122:511-7. 
 
33. MacGlashan DW, Lichtenstein LM. Studies of antigen binding on human basophils, I: 
antigen binding and functional consequences. J Immunol 1983;130:2330-6. 
 
34. MacGlashan DW Jr. Releasability of human basophils: cellular sensitivity and maximal 
histamine release are independent variables. J Allergy Clin Immunol 1993;91:605-15. 
 
35. Fox CC, Kagey-Sobotka A, Schleimer RP, Peters SP, MacGlashan DW Jr, Lichtenstein LM. 
Mediator release from human basophils and mast cells from lung and intestinal mucosa. Int Arch 
Allergy Appl Immunol 1985;77:130-6. 
 
36. Chabay R, DeLisi C, Hook WA, Siraganian RP. Receptor cross-linking and histamine release 
in basophils. J Biol Chem 1980;255:4628-35. 
 
37. Nguyen K-L, Gillis S, MacGlashan DW Jr. A comparative study of releasing and 
nonreleasing human basophils: nonreleasing basophils lack an early component of the signal 
transduction pathway that follows IgE cross-linking. J Allergy Clin Immunol 1990;85:1020-9. 
 
38. Black KM, Lussier AM, Gion WR, Kasaian MT. Cytokine priming of human basophils: 
description of allergen ‘nonreleasers.’ Int Arch Allergy Immunol 1996;111:142-51. 
 
39. Ishizaka T, Soto CS, Ishizaka K. Mechanisms of passive sensitization, III: number of IgE 
molecules and their receptor sites on human basophil granulocytes. J Immunol 1973;111:500-11. 
 
40. Warner JA, Peters SP, Lichtenstein LM, Hubbard W, Yancey KB, Stevenson HC, et al. 
Differential release of mediators from human basophils: differences in arachidonic acid 
metabolism following activation by unrelated stimuli. J Leukocyte Biol 1989;45:558-71. 
 
41. Massey WA, Randall TC, Kagey-Sobotka A,Warner JA, MacDonald SM, Gillis S, et al. 
Recombinant human IL-1a and -1ß potentiate IgE-mediated histamine release from human 
basophils. J Immunol 1989;143:1875-80. 
 
42. Bischoff SC, De Weck AL, Dahinden CA. Interleukin 3 and granulocyte/macrophage-
colony-stimulating factor render human basophils responsive to low concentrations of 
complement component C3a. Proc Natl Acad Sci U S A 1990;87:6813-7. 
 
43. Bischoff SC, Brunner T, De Weck AL, Dahinden CA. Interleukin 5 modifies histamine 
release and leukotriene generation by human basophils in response to diverse agonists. J Exp 
Med 1990;172:1577-82. 
 
44. Bischoff SC, Krieger M, Brunner T, Rot A, Tscharner V, Baggiolini M, et al. RANTES and 
related chemokines activate human basophil granulocytes through different G protein-coupled 
receptors. Eur J Immunol 1993;23:761-7. 
 
45. Dahinden CA, Krieger M, Brunner T, Bischoff SC. Basophil activation by members of the 
chemokine superfamily. Adv Exp Med Biol 1993;351:99-110. 
 
46. Kaplan AP, Baeza M, Reddigari S, Kuna P. Histamine releasing factors. Clin Exp Allergy 
1991;21(suppl. 1):8-16. 
 
47. Kuna P, Reddigari SR, Rucinski D, Oppenheim JJ, Kaplan AP. Monocyte chemotactic and 
activating factor is a potent histamine-releasing factor for human basophils. J Exp Med 
1992;175:489-93. 
 
48. Reddigari SR, Kuna P, Miragliotta GF, Kornfeld D, Baeza ML, Castor CW, et al. Connective 
tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine 
from human basophils. J Allergy Clin Immunol 1992;89:666-72. 
 
49. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Sadick M, Kaplan AP. Characterization of the 
human basophil response to cytokines, growth factors, and histamine releasing factors of the 
intercrine/chemokine family. J Immunol 1993;150:1932-43. 
 
50. Kepley CL, Craig SS, Schwartz LB. Identification and partial characterization of a unique 
marker for human basophils. J Immunol 1995;154:6548-55. 
 
51. Kamps MP. Generation and use of anti-phosphotyrosine antibodies for immunoblotting. 
Methods Enzymol 1991;201:101-10. 
 
52. Riske F, Hakim J, Mallamaci M, Griffin M, Pilson B, Tobkes N, et al. High affinity human 
IgE receptor (FceRI): analysis of functional domains of the a-subunit with monoclonal 
antibodies. J Biol Chem 1991;266:11245-51. 
 
53. Taniguchi T, Kobayashi T, Kondo J, Takahashi K, Nakamura H, Suzuki J, et al. Molecular 
cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high 
susceptibility to proteolysis. J Biol Chem 1991;266:15790-6. 
 
54. Kepley C, Craig S, Schwartz L. Purification of human basophils by density and size alone. J 
Immunol Methods 1994;175:1-9. 
 
55. Bjerke T, Nielsen S, Helgestad J, Nielsen BW, Schiotz PO. Purification of human blood 
basophils by negative selection using immunomagnetic beads. J Immunol Methods 1993;157:49-
56. 
 
56. Becker EL. The relationship of the chemotactic behavior of the complement-derived factors, 
C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 
1 of rabbit polymorphonuclear leukocytes. J Exp Med 1972;135:376-87. 
 
57. Oliver JM, Burg DL,Wilson BS, McLaughlin JL, Geahlen RL. Inhibition of mast cell FceRI-
mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J Biol Chem 
1994;269:29697-703. 
 
58. Wilson BS, Kapp N, Lee RJ, Pfeiffer JR, Martinez AM, Platt Y, et al. Distinct functions of 
the FceRI g and b subunits in the control of FceRI-mediated tyrosine kinase activation and 
signaling responses in RBL-2H3 mast cells. J Biol Chem 1995;270:4013-22. 
 
59. Law CL, Sidorenko SP, Chandran KA, Draves KE, Chan AC,Weiss A, et al. Molecular 
cloning of human Syk: A B cell protein-tyrosine kinase associated with the surface 
immunoglobulin M-B cell receptor complex. J Biol Chem 1994;269:12310-9. 
 
60. Clark MR, Campbell KS, Kazlauskas A, Johnson SA, Hertz M, Potter TA, et al. The B cell 
antigen receptor complex: association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. 
Science 1992;258:123-6. 
 
61. Huby RDJ, Iwashima M, Weiss A, Ley SC. ZAP-70 protein tyrosine kinase is constitutively 
targeted to the T cell cortex independently of its SH2 domains. J Cell Biol 1997;137:1639-49. 
 
62. Hamawy MM, Mergenhagen SE, Siraganian RP. Protein tyrosine phosphorylation as a 
mechanism of signalling in mast cells and basophils. Cell Signal 1995;7:535-44. 
 
63. Dembo M, Goldstein B. A model of cell activation and desensitization by surface 
immunoglobin: the case of histamine release from human basophils. Cell 1980;22:59-67. 
 
64. Kagey-Sobotka A, MacGlashan DW, Lichtenstein LM. Role of receptor aggregation in 
triggering IgE-mediated reactions. Fed Proc 1982;41:12-6. 
 
65. Stanley E, Ralph S, McEwen S, Boulet I, Holtzman DA, Lock P, et al. Alternatively spliced 
murine lyn mRNAs encode distinct proteins. Mol Cell Biol 1991;11:3399-406. 
 
66. Yi TL, Bolen JB, Ihle JN. Hematopoietic cells express two forms of lyn kinase differing by 
21 amino acids in the amino terminus. Mol Cell Biol 1991;11:2391-8. 
 
67. Eiseman E, Bolen JB. src-related tyrosine protein kinases as signaling components in 
hematopoietic cells. Cancer Cells 1990;2:303-10. 
 
68. Yamanashi Y, Mori S,Yoshida M, Kishimoto T, Inoue K,Yamamoto T, et al. Selective 
expression of a protein-tyrosine kinase, p56lyn, in hematopoietic cells and association with 
production of human T-cell lymphotropic virus type I. Proc Natl Acad Sci U S A 1989;86:6538-
42. 
 
69. Hutchcroft JE, Harrison ML, Geahlen RL. Association of the 72-kDa protein-tyrosine kinase 
PTK72 with the B cell antigen receptor. J Biol Chem 1992;267:8613-9. 
 
70. Agarwal A, Salem P, Robbins KC. Involvement of p72syk, a protein-tyrosine kinase, in Fcg 
receptor signaling. J Biol Chem 1993;268:15900-5. 
 
71. Taniguchi T, Kitagawa H, Yasue S, Yanagi S, Sakai K, Asahi M, et al. Protein-tyrosine 
kinase p72syk is activated by thrombin and is negatively regulated through Ca2+ mobilization in 
platelets. J Biol Chem 1993;268:2277-9. 
 
72. Chan AC, Irving BA, Fraser JD, Weiss A. The zeta chain is associated with a tyrosine kinase 
and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine 
phosphoprotein. Proc Natl Acad Sci USA 1991;88:9166-70. 
 
73. Chan AC, van Oers NS, Tran A, Turka L, Law CL, Ryan JC, et al. Differential expression of 
ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases 
in TCR signaling. J Immunol 1994;152:4758-66. 
 
74. Chan AC, Iwashima M, Turck CW, Weiss A. ZAP-70: a 70 kd protein-tyrosine kinase that 
associates with the TCR-z chain. Cell 1992;71:649-62. 
 
75. Bu JY, Shaw AS, Chan AC. Analysis of the interaction of ZAP-70 and syk protein-tyrosine 
kinases with the T-cell antigen receptor by plasmon resonance. Proc Natl Acad Sci U S A 
1995;92:5106-10. 
 
76. Park JG, Schreiber AD. Determinants of the phagocytic signal mediated by the type IIIA Fcg 
receptor, FcgRIIIA: sequence requirements and interaction with protein-tyrosine kinases. Proc 
Natl Acad Sci U S A 1995;92:7381-5. 
 
77. Howard FD, Rodewald HR, Kinet JP, Reinherz EL. CD3 z subunit can substitute for the 
subunit of Fce receptor type I in assembly and functional expression of the high-affinity IgE 
receptor: evidence for interreceptor complementation. Proc Natl Acad Sci U S A 1990;87:7015-
9. 
 
78. Shores E, Flamand V, Tran T, Grinberg A, Kinet JP, Love PE. FceRI g can support T cell 
development and function in mice lacking endogenous TCR z-chain. J Immunol 1997;159:222-
30. 
 
79. Benhamou M, Feuillard J, Lortholary O, Bourgeois C, Michel L, LeGoff, L, et al. Protein 
tyrosine kinases in activation signal of human basophils through the immunoglobulin E receptor 
type l. J Leukoc Biol 1996;59:461-70. 
 
80. Marone G, Kagey-Sobotka A, Lichtenstein LM. IgE-mediated histamine release from human 
basophils: differences between antigen E- and anti-IgE-induced secretion. Int Arch Allergy Appl 
Immunol 1981;65:339-48. 
 
81. MacGlashan DW Jr, Peters SP, Warner J, Lichtenstein LM. Characteristics of human 
basophil sulfidopeptide leukotreine release: releasability defined as the ability of basophils to 
respond to dimeric cross-links. J Immunol 1986;136:2231-9. 
 
82. Lichtenstein LM, Levy DA, Ishizaka K. In vitro reversed anaphylaxis: characteristics of anti-
IgE mediated histamine release. Immunology 1970;19:831-42. 
 
83. Maeyama K, Hohman RJ, Ali H, Cunha-Melo JR, Beaven MA. Assessment of IgE-receptor 
function through measurement of hydrolysis of membrane inositol phospholipids: new insights 
on the phenomena of biphasic antigen concentration-response curves and desensitization. J 
Immunol 1988;140:3919-27. 
 
84. Weetall M, Holowka D, Baird B. Heterologous desensitization of the high affinity receptor 
for IgE (FceRI) on RBL cells. J Immunol 1993;150:4072-83. 
 
85. McCloskey MA. Immobilization of Fce receptors by wheat germ agglutinin: receptor 
dynamics in IgE-mediated signal transduction. J Immunol 1993;151:3237-51. 
 
86. Wofsy C, Kent UM, Mao SY, Metzger H, Goldstein B. Kinetics of tyrosine phosphorylation 
when IgE dimers bind to Fc-e receptors on rat basophilic leukemia cells. J Biol Chem 
1995;270:20264-72. 
 
87. Paolini R, Serra A, Kinet JP. Persistence of tyrosine-phosphorylated FceRI in deactivated 
cells. J Biol Chem 1996;271:15987-92. 
 
88. Brown MT, Cooper JA. Regulation, substrates and functions of src. Biochim Biophys Acta 
1996;1287:121-49. 
 
89. Osborne MA, Zenner G, Lubinus M, Zhang X, Songyang Z, Cantley LC, et al. The inositol 
5’-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE 
receptor aggregation. J Biol Chem 1996;271:29271-8. 
